Compare SFIX & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SFIX | AQST |
|---|---|---|
| Founded | 2011 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 510.6M | 529.4M |
| IPO Year | 2017 | 2007 |
| Metric | SFIX | AQST |
|---|---|---|
| Price | $4.06 | $4.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $4.50 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 2.3M | 1.4M |
| Earning Date | 06-09-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.44 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,226,505,000.00 | $67,430,000.00 |
| Revenue This Year | $8.04 | $10.08 |
| Revenue Next Year | $3.73 | $49.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 25.52 | 0.77 |
| 52 Week Low | $2.95 | $2.94 |
| 52 Week High | $5.92 | $7.55 |
| Indicator | SFIX | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 57.89 | 69.70 |
| Support Level | $3.94 | $3.74 |
| Resistance Level | $4.22 | $5.02 |
| Average True Range (ATR) | 0.29 | 0.18 |
| MACD | 0.05 | 0.07 |
| Stochastic Oscillator | 74.47 | 96.61 |
Stitch Fix Inc offers personal style services for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandise with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types, and price points including Women's, Petite, Maternity, Men's, and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags and sells merchandise across various ranges of price points.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.